TheraRadar
Data updated: Nov 8, 2026

PIPERACILLIN AND TAZOBACTAM AND SODIUM CHLORIDE IN DUPLEX CONTAINER (piperacillin sodium) · B BRAUN MEDICAL

Infectious Disease Approved 2025-04-03

Piperacillin and Tazobactam for Injection and Sodium Chloride Injection, is a combination of piperacillin, a penicillin-class antibacterial and tazobactam, a beta-lactamase inhibitor, indicated for the treatment of: Intra-abdominal infections in adult and pediatric patients 2 months of age and older Nosocomial pneumonia in adult and pediatric patients 2 months of age and older Skin and skin structure infections in adults Female pelvic infections in adults Community-acquired pneumonia in adults U...

1
Indication
--
Phase 3 Trials
1
Years on Market

Details

Status
Prescription
First Approved
2025-04-03
Routes
INTRAVENOUS
Dosage Forms
POWDER

Companies

Active Ingredient: PIPERACILLIN SODIUM , TAZOBACTAM SODIUM

PIPERACILLIN AND TAZOBACTAM AND SODIUM CHLORIDE IN DUPLEX CONTAINER Approval History

2026
Original
New Indication
New Form
Label Update
3 FDA actions from 2025 to 2025
Apr 2025 ORIGINAL
Update · Type 5 - New Formulation or New Manufacturer

What PIPERACILLIN AND TAZOBACTAM AND SODIUM CHLORIDE IN DUPLEX CONTAINER Treats

7 indications

PIPERACILLIN AND TAZOBACTAM AND SODIUM CHLORIDE IN DUPLEX CONTAINER is approved for 7 conditions since its original approval in 2025. These indications span multiple therapeutic areas including oncology, immunology, and more.

Source: FDA Label

PIPERACILLIN AND TAZOBACTAM AND SODIUM CHLORIDE IN DUPLEX CONTAINER Competitive Set

Pro

Three rings of competition based on shared molecular targets and treated indications.

Unlock 8 more competitors across all three rings.
Upgrade to Pro

Filters applied: drops same-active-ingredient (505(b)(2) reformulations), route-mismatch (topical vs systemic), and cross-therapeutic-area matches in same-indication rings.

Drugs Similar to PIPERACILLIN AND TAZOBACTAM AND SODIUM CHLORIDE IN DUPLEX CONTAINER

3 of 20

FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.

ZOSYN IN PLASTIC CONTAINER
PIPERACILLIN SODIUM
7 shared
Baxter
Shared indications:
ERTAPENEM SODIUM
ERTAPENEM SODIUM
3 shared
GLAND
INVANZ
ERTAPENEM SODIUM
3 shared
Merck
🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...
⭐

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
📊

Trial Timeline

Full development history with FDA approval milestones

|
Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

PIPERACILLIN AND TAZOBACTAM AND SODIUM CHLORIDE IN DUPLEX CONTAINER FDA Label Details

Indications & Usage

FDA Label (PDF)

Piperacillin and Tazobactam for Injection and Sodium Chloride Injection, is a combination of piperacillin, a penicillin-class antibacterial and tazobactam, a beta-lactamase inhibitor, indicated for the treatment of: Intra-abdominal infections in adult and pediatric patients 2 months of age and older Nosocomial pneumonia in adult and pediatric patients 2 months of age and older Skin and skin structure infections in adults Female pelvic infections in adults Community-acquired pneumonia in adults Usage to Reduce Development of Drug-Resistant Bacteria To reduce the development of drug-resistant ba...

Track PIPERACILLIN AND TAZOBACTAM AND SODIUM CHLORIDE IN DUPLEX CONTAINER with TheraRadar Pro

Watchlist alerts, full database access, CSV exports across 14,000+ drugs.

Upgrade to Pro

Data Sources

Data sourced from official FDA and NIH databases. Click links to verify on original sources.